Ultralife Corporation posted Q4 2024 revenue of $43.9 million, down slightly year-over-year. Profitability metrics, including net income and operating income, decreased, largely due to one-time costs related to the Electrochem acquisition and a sharp decline in Communications Systems revenue. Adjusted EBITDA and gross margin also declined compared to the prior year.
Revenue was $43.9 million, including $6.1 million from Electrochem.
Net income dropped to $194,000, with diluted EPS at $0.01.
Adjusted EBITDA declined to $3.9 million from $4.8 million last year.
Communications Systems revenue fell 55.1% to $4.0 million.
Ultralife expects profitable growth in 2025 driven by backlog strength, product launches, and integration synergies from Electrochem.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance